Histochemical and stereological analysis of putative preneoplastic hepatic lesions.
Histochemistry is a valuable tool in the analysis of altered hepatic foci. These lesions contain alterations in the activities of certain enzymes, including gamma-glutamyl transpeptidase (GGT), placental glutathione-S-transferase (PGST), glucose-6-phosphatase (G6Pase), and ATPase, or in certain cellular functions, such as the ability to store iron. The appearance of altered hepatic foci has been found to correlate with the later appearance of hepatocellular carcinomas in rodents. The markers PGST and GGT are the most sensitive at detecting altered hepatic foci induced by most chemicals, but are unable to detect altered hepatic foci induced by some agents, such as peroxisome proliferators. Other markers, such as ATPase or G6Pase, should therefore be used in combination with PGST or GGT in identifying altered hepatic foci. The strain of rat used and the type of diet fed also influence the number of altered hepatic foci induced and the enzyme markers seen. The number of foci per cm2 and the diameters of altered hepatic foci in histochemically-stained tissue sections can easily be quantified. The number of foci per cm2, however, does not give a reliable estimate of the number of altered hepatic foci induced because larger altered hepatic foci are more likely to be transected. The equations of quantitative stereology therefore should be used to transform the data to obtain the number of foci induced per cm3 or per liver, the average volume of individual foci, and the percent of the liver volume occupied by altered hepatic foci. In conclusion, the use of histochemistry to identify preneoplastic lesions and the use of quantitative stereology to estimate their number and volume allow accurate and sensitive quantitation of altered hepatic foci.
Glauert
H P
HP
Department of Nutrition and Food Science, Univ. of Kentucky, Lexington.
D000818:Animals; D014408:Biomarkers, Tumor; D015197:Carcinogenicity Tests; D006651:Histocytochemistry; D008114:Liver Neoplasms, Experimental / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D010641:Phenotype; D011230:Precancerous Conditions / Q000209:etiology / Q000378:metabolism* / Q000473:pathology
D014408:Biomarkers, Tumor